A randomized phase II, open-label study of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC).
Eric Jay Small
No relevant relationships to disclose
Raymond Lance
No relevant relationships to disclose
Thomas A. Gardner
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Research Funding - Dendreon
Lawrence Ivan Karsh
Consultant or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Dendreon; Dendreon; Dendreon; Dendreon; GlaxoSmithKline; GlaxoSmithKline; Janssen Pharmaceutical ; Janssen Pharmaceutical ; Medivation; Medivation; Pfizer; Pfizer
Honoraria - Amgen; Amgen; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Dendreon; Dendreon; Dendreon; Dendreon; GlaxoSmithKline; GlaxoSmithKline; Janssen Pharmaceutical ; Janssen Pharmaceutical ; Medivation; Medivation; Pfizer; Pfizer
Research Funding - Amgen; Argos Therapeutics; Astellas Pharma; Bayer; Dendreon; Dendreon; Dendreon; Dendreon; Endo Pharmaceuticals; GlaxoSmithKline; Janssen Pharmaceutical ; Medivation; NeoGenomics Laboratories; Nymox Pharmaceutical Corporation ; Orion Corporation ; Pfizer; Spectrum Pharmaceuticals
Andrew Stubbs
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Other Remuneration - Dendreon
Candice McCoy
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Todd DeVries
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Charles H. Redfern
Research Funding - Sharp Clinical Oncology Research
Neal D. Shore
Consultant or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Dendreon; Dendreon; Janssen Pharmaceutical ; Janssen Pharmaceutical ; Sanofi ; Sanofi